Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C

Slides:



Advertisements
Similar presentations
Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis  Sesh Kamal Sunkara, Jyotsna Pundir,
Advertisements

Programmes and prospects for ovotechnology
Cancer and fertility: strategies to preserve fertility
Attitudes and policies regarding access to fertility care and assisted reproductive technologies in Israel  Daniel Sperling, Yael Simon  Reproductive.
Diet and endometriosis risk: A literature review
Fresh and cryopreserved ovary transplantation and resting follicle recruitment  Sherman Silber, Jorge Pineda, Kathleen Lenahan, Michael DeRosa, Jeffrey.
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
Norbert Gleicher, Andrea Weghofer, David H. Barad 
Protective effect of resveratrol against oxidative damage to ovarian reserve in female Sprague–Dawley rats  Pınar Özcan, Cem Fıçıcıoğlu, Özge Kızılkale.
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study  Thi.
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response  William L. Ledger, Bart C.J.M. Fauser, Paul.
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction  Antonio La Marca, Giovanni D’Ippolito 
N. la Cour Freiesleben, T. A. Gerds, J. L. Forman, J. D. Silver, A
Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol  Qi Yao, Yuanjiao Liang, Yong.
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH  George Griesinger, Daniel B. Shapiro, Efstratios.
Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors  Nikolaos P. Polyzos, Dominic Stoop, Christophe.
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation 
Ovarian response to 150 µg corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study  Tamara Lerman, Marion Depenbusch,
Amir Wiser, Einat Shalom-Paz, Jordana H
HDlive ultrasound images in assisted reproduction treatment
Establishment and validation of a score to predict ovarian response to stimulation in IVF  Clelia Chalumeau, Jessika Moreau, Nicolas Gatimel, Clementine.
Anti-Müllerian hormone as a predictor of pregnancy following IVF
Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles  Reshef Tal, David B. Seifer, Moisey Khanimov, Eliana.
Sherman Silber  Reproductive BioMedicine Online 
Why are reproductive cancers more common in nulliparous women?
Perinatal outcomes after stimulated versus natural cycle IVF: a systematic review and meta-analysis  Mohan Shashikant Kamath, Richard Kirubakaran, Mariano.
K. Gersak, A. Veble  Reproductive BioMedicine Online 
Utility of age-specific serum anti-Müllerian hormone concentrations
Sarah McCredie, William Ledger, Christos A. Venetis 
Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study  A. Nasr  Reproductive BioMedicine Online 
Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.
Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis  Georg Griesinger, Robert Boostanfar, Keith.
M. Dieterich, M. Bolz, T. Reimer, S. Costagliola, B. Gerber 
Removal of unilateral endometriomas is associated with immediate and sustained reduction in ovarian reserve  Bulent Urman, Ebru Alper, Kayhan Yakin, Ozgur.
Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa  F. Olivennes, G. Trew,
Reproductive BioMedicine Online
Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational.
Cross-border reproductive care: a review of the literature
Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial  Vivian Chi Yan Lee, Carina Chi Wai Chan,
Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype  C. Dechanet, C. Castelli,
Ronit Machtinger, Raoul Orvieto  Reproductive BioMedicine Online 
A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor  X.J. Sun, L. Jiang, L.C. Ji, R. Nie,
Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors  Alberta Maria Fabris, Maria Cruz, Carlos Iglesias,
V Isachenko, E Isachenko, R Kreienberg, M Woriedh, JM Weiss 
Does ovarian stimulation regimen affect IVF outcome
Should we be promoting embryo transfer at blastocyst stage?
Stephen C. Collins, Esther Chan  Reproductive BioMedicine Online 
Ovarian stimulation and endometriosis progression or recurrence: a systematic review  Edgardo Somigliana, Paola Viganò, Laura Benaglia, Andrea Busnelli,
Pietro Gambadauro, Ramesan Navaratnarajah 
Variation in antral follicle counts at different times in the menstrual cycle: does it matter?  Dimitrios Mavrelos, Ali Al Chami, Vikram Talaulikar, Elizabeth.
Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature  Micah J. Hill, Gary Levy, Eric D. Levens 
Genome-wide analysis shows no genomic predictors of ovarian response to stimulation by exogenous FSH for IVF  Jeroen van Disseldorp, Lude Franke, Rene.
Jeff G. Wang, Nataki C. Douglas, Gary S. Nakhuda, Janet M
The Alpha Consensus Meeting on the professional status of the clinical embryologist: proceedings of an expert meeting    Reproductive BioMedicine Online 
Response: time-lapse systems for ART
A. La Marca, S. M. Nelson, G. Sighinolfi, M. Manno, E. Baraldi, L
Is parental consanguinity associated with reduced ovarian reserve?
Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility  C.M. Howles, V. Alam, D. Tredway, R. Homburg,
Nigel Pereira, Anna Voskuilen-Gonzalez, Kolbe Hancock, Jovana P
Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF  Thomas Freour, Lionel Dessolle, Miguel Jean, Damien Masson,
Ovarian reserve screening before contraception?
Cryobanking of human ovarian tissue: do women still want their tissue stored beyond 5 years?  Kirsten Tryde Macklon, Erik Ernst, Anders Nyboe Andersen,
The significance of the number of CGG repeats and autoantibodies in premature ovarian failure  Cem Fıçıcıoglu, Gazi Yildirim, Rukset Attar, Banu Kumbak,
Programmes and prospects for ovotechnology
Randomized controlled trial of benzocaine versus placebo spray for pain relief at hysterosalpingogram  E.A. Bachman, S. Senapati, M.D. Sammel, S.K. Kalra 
John Yovich, James Stanger, Peter Hinchliffe 
M. Franz, J. Ott, A. Watrelot, L. Küssel, H. Husslein 
A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive.
Presentation transcript:

Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH  Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P.C. Wong, Colin M Howles  Reproductive BioMedicine Online  Volume 27, Issue 4, Pages 390-399 (October 2013) DOI: 10.1016/j.rbmo.2013.07.008 Copyright © 2013 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Anti-Müllerian hormone (AMH) cut-off values to predict hyporesponse (A) or hyperresponse (B) to ovarian stimulation. Reproductive BioMedicine Online 2013 27, 390-399DOI: (10.1016/j.rbmo.2013.07.008) Copyright © 2013 Reproductive Healthcare Ltd. Terms and Conditions

Figure 2 Antral follicle count (AFC) cut-off to predict hyporesponse (A) or hyperresponse (B) to ovarian stimulation. Reproductive BioMedicine Online 2013 27, 390-399DOI: (10.1016/j.rbmo.2013.07.008) Copyright © 2013 Reproductive Healthcare Ltd. Terms and Conditions